CYPHERPUNK TECHNOLOGIES INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $5.25 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $5.25M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $2.74M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $967.00K.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $12.10M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-12-31 | $5.25M 10-K · filed 2026-03-16 |
| 2024-12-31 | $2.74M 10-K · filed 2026-03-16 |
| 2023-12-31 | $967.00K 10-K · filed 2025-03-26 |
| 2022-12-31 | $12.10M 10-K · filed 2024-03-18 |
| 2021-12-31 | $11.25M 10-K · filed 2023-03-24 |
| 2020-12-31 | $8.96M 10-K · filed 2022-03-11 |
| 2019-12-31 | $7.43M 10-K · filed 2021-03-12 |
| 2018-12-31 | $5.55M 10-K · filed 2020-03-16 |
| 2017-12-31 | $4.01M 10-K · filed 2019-04-01 |
| 2016-12-31 | $1.86M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |